THEY SAID IT: LAWMAKERS EXPOSE BIG PHARMA’S EGREGIOUS PRICE HIKES AND ANTI-COMPETITIVE TACTICS — DEBUNK BLAME GAME AND EXCUSES
Oct 1, 2020
Lawmakers Blast Big Pharma Executives During Two-Day Hearing on… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
DOSE OF REALITY: LAWMAKERS RIGHT TO TRAIN RENEWED FOCUS ON BIG PHARMA’S PRICE-GOUGING AND ANTI-COMPETITIVE TACTICS
Sep 29, 2020
Brand Name Drug Companies Must be Held Accountable for Pandemic Price Hikes… Read More
DOSE OF REALITY: TRUMP ADMINISTRATION MUST DUMP REBATE RULE TO ACHIEVE SECOND TERM GOAL OF LOWERING PREMIUMS
Aug 26, 2020
Misguided Measure Would Increase Medicare Part D Premiums, Cost Taxpayers More… Read More
DOSE OF REALITY: DEBUNKING BIG PHARMA’S SUPPLY CHAIN BLAME GAME
Aug 14, 2020
Drug Companies Target PBMs and Rebates That Play a Critical Role in Lowering… Read More
BIG PHARMA EARNINGS WATCH: BRISTOL-MYERS SQUIBB
Aug 6, 2020
Brand Name Drug Company Completes Sweep of Big Pharma Giants Who Beat Wall… Read More
DOSE OF REALITY: UNPACKING THE REBATE RULE’S BIG PHARMA ORIGINS
Aug 3, 2020
Little Surprise Big Pharma Bailout That Would Hike Medicare Premiums Was A… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE & MERCK
Jul 31, 2020
Brand Name Drug Companies Continue Streak of Beating Wall Street Expectations… Read More
Big Pharma Earnings Watch: AstraZeneca & Eli Lilly
Jul 31, 2020
Brand Name Drug Companies See Soaring Profits After Hiking Prices Today… Read More
BIG PHARMA EARNINGS WATCH: SANOFI
Jul 29, 2020
Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giant… Read More
BIG PHARMA EARNINGS WATCH: PFIZER & AMGEN
Jul 29, 2020
Brand Name Big Pharma Giants Surpass Expectations After Hiking Prices New… Read More
THEY SAID IT! COVERAGE HIGHLIGHTS REVIVED REBATE RULE AN UNWORKABLE BIG PHARMA BAILOUT
Jul 28, 2020
Reception of Misguided Reboot Focuses on Premium Increases, Cost to Taxpayers,… Read More
THEY SAID IT: GOP AND CONSERVATIVE LEADERS CONCERNED WITH NEGATIVE IMPACT OF REBATE RULE
Jul 22, 2020
HHS Secretary, Republican Lawmakers, Right-of-Center Policy Experts and… Read More